Summa Reports First-In-Man Experience

CAMBRIDGE, Massachusetts, January 17, 2024— Summa Therapeutics, LLC announced today that the first-in-man injectable angioplasty procedures for patients with below-knee peripheral arterial disease (PAD) were performed successfully using its Finesse[…]

Read more